Trial intelligence / Profile preview

Cloderm Cream in moderate plaque psoriasis

NCT01714544Phase 4Completed

Sponsor
Promius Pharma
Start
Oct 2012
Primary completion
Mar 2013
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of clocortolone pivalate in plaque psoriasis, sponsored by Promius Pharma. Primary endpoint: Investigator's Global Assessment at 28 days. Started Oct 2012; status: completed.

02

Drugs

clocortolone pivalate
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT01714544.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01714544.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call